Biomedical Advanced Research and Development Authority
-
Malvern-Based Venatorx Secures Up to $167 Million for Antibiotic Development
Malvern-based antibiotics firm Venatorx Pharmaceuticals has been awarded its third government contract, potentially worth up to $167 million, to develop treatments for multi-drug-resistant bacterial and…
-
Malvern Company Readies for FDA Submission of COVID-19 Vaccine
Later this month, Malvern-based Ocugen will seek an emergency-use authorization from the FDA to cooperate with Bharat Biotech for the India-based company’s COVID-19 vaccine, Covaxin,…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
